Skip to main content Skip to section navigation Skip to footer

Vyant Bio, Inc.

  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In the News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Contacts
    • FAQ
  • Documents
    • Presentations
    • Scientific Documents
    • Videos
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix

Presentations

Documents

Documents

  • Presentations
  • Scientific Documents
  • Videos
Vyant Bio attends the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, January 8th to 11th  2023
Jan 12, 2023

Vyant Bio attends the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, January 8th to 11th 2023

Presentation by Andrew LaCroix, PhD “Multiparametric analysis of coordinated network activity reveals target-specific functional rescue in a human iPSC-derived organoid model of Rett syndrome
Nov 17, 2022

Presentation by Andrew LaCroix, PhD “Multiparametric analysis of coordinated network activity reveals target-specific functional rescue in a human iPSC-derived organoid model of Rett syndrome

Dr. Cassiano Carromeu presentation at the Rett Nanosymposium at Neuroscience 2022, hosted by the Society for Neuroscience identifying Vyant Bio’s therapeutic candidate for Rett syndrome with a differentiated mechanism of action
Nov 16, 2022

Dr. Cassiano Carromeu presentation at the Rett Nanosymposium at Neuroscience 2022, hosted by the Society for Neuroscience identifying Vyant Bio’s therapeutic candidate for Rett syndrome with a differentiated mechanism of action

Vyant Bio Third Quarter 2022 Conference Call & Webcast
Nov 15, 2022

Vyant Bio Third Quarter 2022 Conference Call & Webcast

Presentation by Matt Green, PhD “High-throughput functional screening to develop novel therapies for CDKL5-deficiency disorder using human iPSC-derived cortical organoids”, 2022 CDKL5 Forum hosted by the Loulou Foundation
Nov 10, 2022

Presentation by Matt Green, PhD “High-throughput functional screening to develop novel therapies for CDKL5-deficiency disorder using human iPSC-derived cortical organoids”, 2022 CDKL5 Forum hosted by the Loulou Foundation

Vyant Bio Skyline Signature Series Presentation
Sep 8, 2022

Vyant Bio Skyline Signature Series Presentation

Vyant Bio Second Quarter 2022 Conference Call & Webcast
Aug 15, 2022

Vyant Bio Second Quarter 2022 Conference Call & Webcast

Vyant Bio Investor Presentation – H.C. Wainwright Global Conference – May 2022
May 23, 2022

Vyant Bio Investor Presentation – H.C. Wainwright Global Conference – May 2022

Vyant Bio First Quarter 2022 Conference Call & Webcast
May 16, 2022

Vyant Bio First Quarter 2022 Conference Call & Webcast

Vyant Bio Appoints Biotech Veteran Robert Fremeau as Chief Scientific Officer
Nov 2, 2021

Vyant Bio Appoints Biotech Veteran Robert Fremeau as Chief Scientific Officer

RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

Contact Us

Global locations in the US, Europe, and Australia.

Twitter LinedIn
©2023 Vyant Bio, Inc. All Rights Reserved.